Biocept Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BIOC Nasdaq 2834 https://biocept.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biocept Inc

High Sensitivity of Biocept's Target Selector™ Platform Using CEE-Sure™ Blood Collection Tubes to Be Featured in Poster Presentation at the 2019 IASLC World Conference on Lung Cancer - Aug 22nd, 2019 6:05 am
Biocept Receives Three Additional Patents Covering its Antibody and Microchannel Technology and Enhanced Detection of Cancer Cells - Aug 13th, 2019 6:05 am
Biocept Reports Second Quarter 2019 Financial Results - Aug 12th, 2019 2:05 pm
Biocept, Inc. to Host Earnings Call - Aug 12th, 2019 12:30 pm
Biocept to Release Second Quarter 2019 Financial Results and Host Investor Conference Call on August 12, 2019 - Aug 5th, 2019 6:05 am
Penny Stocks to Watch for August 2019 - Aug 4th, 2019 8:02 pm
Biocept Announces Laboratory Services Provider Agreement with BeaconLBS® - Jul 22nd, 2019 6:05 am
Does Biocept, Inc. (NASDAQ:BIOC) Have A High Beta? - Jul 16th, 2019 11:31 am
Biocept Announces Commercial Launch of Target Selector™ NGS Breast Panel, the Company's Second Multi-Gene Tumor-Specific Panel - Jun 18th, 2019 6:05 am
Biocept to Present at the 9th Annual LD Micro Invitational Conference on June 4 - Jun 3rd, 2019 6:05 am
Biocept Awarded Patent in China for its Circulating Tumor Cell Platform Expanding Intellectual Property Estate to 33 Issued Patents Globally - May 28th, 2019 6:05 am
Biocept Announces Clinical Validation and Commercial Launch of its Target Selector™ Multi-Gene Liquid Biopsy Panel for Lung Cancer - May 20th, 2019 6:05 am
Biocept Reports First Quarter 2019 Financial Results - May 8th, 2019 2:05 pm
Biocept to Release First Quarter 2019 Financial Results and Host Investor Conference Call on May 8, 2019 - May 1st, 2019 6:05 am
Biocept Reports 2018 Fourth Quarter and Full Year Financial Results - Mar 28th, 2019 2:05 pm
Biocept Broadens Commercial Focus of its Target Selector Liquid Biopsy Platform to Include Urology Market Segment - Mar 26th, 2019 6:05 am
Biocept to Release 2018 Fourth Quarter and Full Year Financial Results and Host Investor Conference Call on March 28, 2019 - Mar 21st, 2019 6:05 am
Biocept Awarded Patent in Japan for the Capture of Rare Cells Including CTCs from Any Biological Sample of Interest with A Microchannel Device - Mar 18th, 2019 6:05 am
Biocept, Potential Near-Term Catalysts for Biocept - Mar 18th, 2019 6:00 am